Permanently Discontinued

MOVAPO

PALADIN LABS INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is MOVAPO discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that MOVAPO 10MG has been permanently discontinued (last updated October 16, 2023). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is MOVAPO not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength10MG

Report last updated2023-10-16

Checked by MedShort2026-11-13

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02459132

Strength

10MG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Active Ingredient

APOMORPHINE HYDROCHLORIDE

See all APOMORPHINE HYDROCHLORIDE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2023-10-16

Active Shortage

Disruption of the manufacture of the drug.